Chandigarh UT Health Dept Marks Inquiry Into Sale Of Branded Drugs At Jan Aushadhi Store

Chandigarh : The UT health department on Friday marked an inquiry to check on the sale of branded medicines at the Jan Aushadhi store at the Government Multi-Specialty Hospital (GMSH), Sector 16, premises.

The development came after a patient, who visited the hospital’s orthopaedics department after getting severe knee pain, filed a written complaint with the UT health director, stating that the Jan Aushadhi store gave her branded medicines in place of the generic ones and also issued a wrong bill.

“The Jan Aushadhi store sold branded medicine to me at a cost of ₹235, but gave me a bill for a purchase amounting to ₹201. The authorities must check on the sale of the store,” the patient said in her complaint.

Addressing the same, UT health secretary Yashpal Garg said, “After receiving the complaint, the drug inspector has been asked to check on the working of the Jan Aushadhi store and to submit a report.”

After the inquiry was marked, the drug inspector conducted a surprise check on the store.

The health department, in a statement said, it was observed during the inspection that the kendra had stocked both Jan Aushadhi drugs and other branded medicines for sale.

“Eight types of branded drugs were seized. Certified copies of certain purchase and sale bills for branded and generic drugs were also taken on record, as evidence of sale of both types of drugs,” it further read.

The statement stated that the matter will be investigated further and that it would consult the Pharmaceuticals and Medical Devices Bureau of India regarding the guidelines related to the sale of drugs.

“If the violations are confirmed, appropriate actions will be taken against the Jan Aushadhi Kendra,” it added.

  • Related Posts

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick